SWOG clinical trial number
SWOG-717
Combination Drug (Cytoxan (NSC-26271), Vincristine (NSC-67574), Methotrexate (NSC-740) and 5-Fluorouracil (NSC-19893) Chemotherapy of Solid Tumor in Adults
Closed
Phase
Accrual
4%
Abbreviated Title
Combination Drug (Cytoxan (NSC-26271), Vincristine (NSC-67574), Methotrexate (NSC-740) and 5-Fluorouracil (NSC-19893) Chemotherapy of Solid Tumor in Adults
Activated
07/29/1968